PLK1-IN-14
Product Specifications
Target
PLK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
PLK1-IN-14 (Compound Hit-4) is a selective PLK1 inhibitor with an IC50 of 22.61 pM for PLK1, and an IC50 of 0.09 nM for inhibiting the proliferation of DU-145 prostate cancer cells. It is applicable in prostate cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
040157-APC 200 µL
PLEKHA9, CT (PLEKHA8P1, Putative protein PLEKHA9, Pleckstrin homology domain-containing family A member 8 pseudogene 1) (APC) discontinued
Sign In for Pricing
View Details 
GTR15226706 1 Vial
Lentiviral mouse Ndufaf1 shRNA (UAS) - Lentiviral mouse Ndufaf1 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details bs-7721R-BF750-TR 20 µL
CAPG2 Polyclonal Antibody, AbBy Fluor™ 750 Conjugated
Sign In for Pricing
View Details 18399061 1.0 µg DNA
DNAJC18 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details